atezolizumab,bevacizumab
roche
['colorectal', 'beat', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'crcsm', 'rectal']
more evidence that egfr inhibitors beat vegf inhibitors as 1st line therapy in #colorectalcancer for left sided, ras/braf/her2-. #asco22 #crcsm 
GI #Oncologist @ClevelandClinic | @USNews contributor | Tweets my own